Insiders / Sohn Catherine A.

Sohn Catherine A.

CIK 1555132personinsider
Companies
2
First seen
Jan 5, 2026
Last activity
May 1, 2026

Companies

CompanyRoleShares heldPeak heldTradesLatest
Altimmune Inc · ALTDirector1,50048,8002
Maze Therapeutics, Inc. · MAZEDirector026,92010

All securities held

3 positions · latest reported per filing
CompanySecuritySharesAs of
Altimmune IncCommon Stock, par value $0.00011,500Jan 5, 2026
Altimmune IncStock Options (option to buy)Derivative48,800May 1, 2026
Maze Therapeutics, Inc.Stock Option (Right to Buy)Derivative5,805Jan 7, 2026

Activity

InsidersInstitutions
This person's insider trades (Form 4), across every company.
DateActionCompanyValueShares ΔPosition afterImpact
Jan 7, 2026SellMAZE
Maze Therapeutics, Inc.
Common Stock
$1.05M-27K
-100.00%
0
0.00% of shares
medium
Jan 7, 2026ExerciseMAZE
Maze Therapeutics, Inc.
Common Stock
$216.2K+21K
20,744
0.04% of shares
low
Jan 6, 2026SellMAZE
Maze Therapeutics, Inc.
Common Stock
$96.3K-2K
-100.00%
0
0.00% of shares
low
Jan 7, 2026ExerciseMAZE
Maze Therapeutics, Inc.
Common Stock
$34.2K+3K
+13.88%
26,920
0.05% of shares
low
Jan 7, 2026ExerciseMAZE
Maze Therapeutics, Inc.
Common Stock
$30.2K+3K
+13.96%
23,639
0.04% of shares
low
Jan 6, 2026ExerciseMAZE
Maze Therapeutics, Inc.
Common Stock
$26.0K+2K
2,493
<0.01% of shares
low
Jan 5, 2026BuyALT
Altimmune Inc
Common Stock, par value $0.0001
$2.1K+500
+50.00%
1,500
<0.01% of shares
low
May 1, 2026GrantALT
Altimmune Inc
Stock Options (option to buy)
+49K
48,800
0.03% of shares
low
Jan 7, 2026ExerciseMAZE
Maze Therapeutics, Inc.
Stock Option (Right to Buy)
-3K
-36.11%
5,805
0.01% of shares
low
Jan 7, 2026ExerciseMAZE
Maze Therapeutics, Inc.
Stock Option (Right to Buy)
-3K
-90.16%
316
<0.01% of shares
low